RELMADA THERAPEUTICS INC (RLMD) Forecast, Price Target & Analyst Ratings

NASDAQ:RLMD • US75955J4022

Current stock price

7.37 USD
-0.11 (-1.47%)
At close:
7.37 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for RELMADA THERAPEUTICS INC (RLMD).

Forecast Snapshot

Consensus Price Target

Price Target
$14.03
+ 90.30% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
-$0.20
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.45%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$14.03
Upside
+ 90.30%
From current price of $7.37 to mean target of $14.03, Based on 11 analyst forecasts
Low
$10.10
Median
$13.26
High
$19.95

Price Target Revisions

1 Month
52.78%
3 Months
37.50%

Price Target Summary

11 Wall Street analysts provided a forecast for the next 12 months for RLMD. The average price target is 14.03 USD. This implies a price increase of 90.3% is expected in the next year compared to the current price of 7.37.
The average price target has been revised upward by 37.5% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

RLMD Current Analyst RatingRLMD Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

RLMD Historical Analyst RatingsRLMD Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
85.45%
RLMD was analyzed by 11 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about RLMD.
In the previous month the buy percentage consensus was at a similar level.
RLMD was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-24Piper SandlerInitiate Overweight
2026-03-20MizuhoMaintains Outperform -> Outperform
2026-03-02LUCID CAPITAL MARKETSInitiate Buy
2026-01-23Leerink PartnersUpgrade Market Perform -> Outperform
2025-12-22JefferiesInitiate Buy
2025-11-19MizuhoUpgrade Neutral -> Outperform
2024-12-05MizuhoDowngrade Outperform -> Neutral
2024-12-04Leerink PartnersDowngrade Outperform -> Market Perform
2024-09-17JefferiesUpgrade Hold -> Buy
2024-06-05Goldman SachsDowngrade Neutral -> Sell
2023-06-15MizuhoReiterate Buy -> Buy
2023-01-23SVB LeerinkMaintains Outperform
2022-10-14GuggenheimDowngrade Buy -> Neutral
2022-10-14Goldman SachsDowngrade Buy -> Neutral
2022-10-13OppenheimerDowngrade Outperform -> Perform
2022-09-23Goldman SachsMaintains Buy
2022-09-06GuggenheimMaintains Buy
2022-05-09OppenheimerMaintains Outperform
2021-12-20SVB LeerinkMaintains Outperform
2021-11-18MizuhoInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
-$0.20
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
65.71%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

RLMD is expected to report earnings on 5/13/2026. The consensus EPS estimate for the next earnings is -0.2 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
RLMD revenue by date.RLMD revenue by date.
N/AN/AN/AN/A
11.28%		N/A
577.38%		N/A
138.33%		N/A
96.33%		N/A
41.62%
EBITDA
YoY % growth
RLMD ebitda by date.RLMD ebitda by date.
-17.09M-16.17M
5.38%		-7.13M
55.91%		-6.92M
2.95%		-12.73M
-83.96%		-60.84M
-377.93%		-125.7M
-106.61%		-161.25M
-28.28%		N/A
34.29%		N/A
15.94%		N/A
-18.54%		N/A
-20.77%		N/AN/AN/A
-14.71%		N/A
44.44%		N/A
206.15%		N/A
208.70%		N/A
65.26%
EBIT
YoY % growth
RLMD ebit by date.RLMD ebit by date.
-17.1M-16.22M
5.15%		-7.22M
55.49%		-6.92M
4.16%		-12.73M
-83.96%		-60.84M
-377.93%		-125.7M
-106.61%		-161.25M
-28.28%		-103.702M
35.69%		-83.891M
19.10%		-59.1M
29.55%		N/A
7.21%		N/A
-62.62%		N/A
-16.32%		N/A
-19.85%		N/A
40.73%		N/A
238.11%		N/A
247.96%		N/A
55.48%
Operating Margin
RLMD operating margin by date.RLMD operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
RLMD eps by date.RLMD eps by date.
N/AN/A
92.46%		N/AN/AN/AN/A-7.14
-93.19%		-5.45
23.67%		-3.28
39.82%		-2.65
19.21%		-1.47
44.53%		N/A
47.27%		N/A
-25.53%		N/A
-2.38%		N/A
-11.60%		N/A
55.96%		N/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.20
65.71%		-0.19
37.95%		-0.20
32.00%		-0.23
20.86%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-20.888M
-14.65%		-21.54M
-110.74%		-23.538M
-127.92%		-26.016M
-27.95%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

RLMD Yearly Revenue VS EstimatesRLMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 2031 2032 2033 200M 400M 600M
RLMD Yearly EPS VS EstimatesRLMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -2 -4 -6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
9.76%
EPS Next 5 Year
10.76%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-27.51%
EBIT Next 5 Year
-5.73%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

RELMADA THERAPEUTICS INC / RLMD Forecast FAQ

What is the price target for RLMD stock?

11 analysts have analysed RLMD and the average price target is 14.03 USD. This implies a price increase of 90.3% is expected in the next year compared to the current price of 7.37.

Can you provide the upcoming earnings date for RELMADA THERAPEUTICS INC?

RELMADA THERAPEUTICS INC (RLMD) will report earnings on 2026-05-13.

Can you provide the consensus estimates for RELMADA THERAPEUTICS INC next earnings?

The consensus EPS estimate for the next earnings of RELMADA THERAPEUTICS INC (RLMD) is -0.2 USD and the consensus revenue estimate is 0 USD.